By Richard Vanderford ( July 28, 2009, 10:54 PM EDT) -- Generic-drug maker Apotex Inc. has asked the U.S. Supreme Court to weigh in on its patent dispute with Bristol-Myers Squibb Co. and Sanofi-Aventis, makers of the blockbuster blood-thinning drug Plavix, saying substances produced by "obvious to try" experiments should not be patentable....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.